BG106404A - Фармацевтичен състав, съдържащ ципрофлоксацин, и метод за неговото получаване - Google Patents

Фармацевтичен състав, съдържащ ципрофлоксацин, и метод за неговото получаване

Info

Publication number
BG106404A
BG106404A BG06404A BG10640402A BG106404A BG 106404 A BG106404 A BG 106404A BG 06404 A BG06404 A BG 06404A BG 10640402 A BG10640402 A BG 10640402A BG 106404 A BG106404 A BG 106404A
Authority
BG
Bulgaria
Prior art keywords
preparation
pharmaceutical composition
composition containing
ciprofloxacin
containing ciprofloxacin
Prior art date
Application number
BG06404A
Other languages
Bulgarian (bg)
English (en)
Inventor
Pal Fekete
Gyoergyne Fellner
Laszlone Gora
Istvanne Jambor
Szilvia Feikus
Zoltanne Palfi
Zsolt Zsigmond
Original Assignee
Egis Gyogyszergyar Rt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Gyogyszergyar Rt. filed Critical Egis Gyogyszergyar Rt.
Publication of BG106404A publication Critical patent/BG106404A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BG06404A 1999-08-11 2002-02-01 Фармацевтичен състав, съдържащ ципрофлоксацин, и метод за неговото получаване BG106404A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9902725A HU227070B1 (en) 1999-08-11 1999-08-11 Immediate release pharmaceutical composition containing ciprofloxacin and process for its production
PCT/HU2000/000090 WO2001012162A1 (en) 1999-08-11 2000-08-11 Ciprofloxacin containing pharmaceutical composition and process for the preparation thereof

Publications (1)

Publication Number Publication Date
BG106404A true BG106404A (bg) 2002-09-30

Family

ID=89999030

Family Applications (1)

Application Number Title Priority Date Filing Date
BG06404A BG106404A (bg) 1999-08-11 2002-02-01 Фармацевтичен състав, съдържащ ципрофлоксацин, и метод за неговото получаване

Country Status (13)

Country Link
EP (1) EP1207857B1 (cs)
AT (1) ATE241967T1 (cs)
AU (1) AU6716100A (cs)
BG (1) BG106404A (cs)
CZ (1) CZ2002505A3 (cs)
DE (1) DE60003196T2 (cs)
HK (1) HK1046234B (cs)
HU (1) HU227070B1 (cs)
PL (1) PL352331A1 (cs)
RU (1) RU2251420C2 (cs)
SK (1) SK285236B6 (cs)
UA (1) UA72270C2 (cs)
WO (1) WO2001012162A1 (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030229101A1 (en) * 2002-06-06 2003-12-11 Sherman Bernard Charles Tablets comprising ciprofloxacin hydrochloride
WO2005021000A1 (en) * 2003-08-28 2005-03-10 Ranbaxy Laboratories Limited Solid oral dosage forms of gatifloxacin
DE10351448A1 (de) * 2003-11-04 2005-06-09 Bayer Healthcare Ag Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
EP1880722B1 (en) * 2006-07-19 2010-03-17 Tabuk Pharmaceutical Manufacturing Co. Pharmaceutical compositions of ciprofloxacin
CN107669645A (zh) * 2017-10-31 2018-02-09 瑞阳制药有限公司 盐酸环丙沙星片的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3601566A1 (de) * 1986-01-21 1987-07-23 Bayer Ag Pharmazeutische zubereitungen von ciprofloxacin
US5837292A (en) * 1996-07-03 1998-11-17 Yamanouchi Europe B.V. Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug
AU3691297A (en) * 1996-08-15 1998-03-06 Losan Pharma Gmbh Easy to swallow oral medicament composition

Also Published As

Publication number Publication date
PL352331A1 (en) 2003-08-11
RU2002106727A (ru) 2004-01-10
HUP9902725A2 (hu) 2001-12-28
DE60003196T2 (de) 2004-04-29
EP1207857A1 (en) 2002-05-29
EP1207857B1 (en) 2003-06-04
HU227070B1 (en) 2010-06-28
ATE241967T1 (de) 2003-06-15
SK285236B6 (sk) 2006-09-07
AU6716100A (en) 2001-03-13
SK2132002A3 (en) 2002-08-06
HU9902725D0 (en) 1999-10-28
RU2251420C2 (ru) 2005-05-10
WO2001012162A1 (en) 2001-02-22
UA72270C2 (en) 2005-02-15
DE60003196D1 (de) 2003-07-10
CZ2002505A3 (cs) 2002-06-12
HK1046234A1 (en) 2003-01-03
HK1046234B (en) 2004-03-19

Similar Documents

Publication Publication Date Title
DE59707812D1 (de) Opioidantagonisthaltige galenische formulierung
TR199903191T2 (xx) Vorikonazol i�eren ila� form�lasyonlar�.
AR036768A1 (es) Formas de administracion de propiverina o sus sales farmaceuticamente aceptables con liberacion prolongada de la sustancia activa
ITRM990338A0 (it) Composizione dietetica o farmaceutica utile per la prevenzione o il trattamento dell'iperossaluria.
HUP9602507A3 (en) Cyclic peptides, adhesion inhibitor pharmaceutical compositions comprising the compounds, process for the preparation of the compounds and the pharmaceutical compositions and the use of the compounds
KR950702827A (ko) 부프로피온 함유 서방형 정제(sustained release tablets containing bupropion)
MY119820A (en) Guanidine mimics as factor xa inhibitors
NO20016198D0 (no) Orale farmasöytiske sammensetninger som inneholder taxaner og fremgangsmåter for anvendelse av samme i behandling
IL132107A0 (en) Substituted phenyl derivatives their preparation and use
AR028504A2 (es) Combinacion, metodo para mejorar la apariencia corporal de un mamifero, composicion farmaceutica, uso de dicha combinacion para la preparacion de un medicamento para la prevencion, demora de progreso, o tratamiento de desordenes metabolicos, y paquete comercial
TR199802108T2 (xx) �bandronat i�eren oral farmas�tik bir form�lasyon.
UA50719C2 (uk) Проліки для терапії пухлин і запальних захворювань
TR199900336T2 (xx) EAA antagonistleri olarak tetrahidrokinolin t�revleri.
EA200500074A1 (ru) Пленочное покрытие для таблеток и каплет
NO20045385L (no) Farmasoytisk preparat inneholdende okskarbazepin med kontrollert frigivelse av aktivt stoff
BG106404A (bg) Фармацевтичен състав, съдържащ ципрофлоксацин, и метод за неговото получаване
KR970061246A (ko) 테스토스테론을 증가시키기 위한 약학 조성물
ATE69164T1 (de) Arzneimittel zur behandlung von uraemie.
NO954952L (no) Fremgangsmåte for fremstilling av en oral fast-stoff doseringsform som inneholder diklofenac
EE04778B1 (et) Hargnenud ahelaga asendatud 3-amino-1-fenüül-1H-[1,2,4]triasooli aminoderivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid
MX9709453A (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.
EE200100596A (et) Ülipuhas (1R,2S,4R)-(-)-2-[(2'-{N,N-dimetüülamino}etoksü)]-2-[fenüül]-1,7,7-tri[metüül]bitsüklo[2.2.1 ]heptaan ja selle farmatseutiliselt vastuvõetavad happeliitsoolad ning nimetatud ühendite, samutiravimite, mis sisaldavad üks või enam nimetatud üh
ECSP003508A (es) Formas polimorfas de un citrato de azobiciclo [2.2.2] octan-3-amina y sus composiciones farmaceuticas
WO2005058310A3 (en) Use of stating for the treatment of metabolic syndrome
ATE14437T1 (de) Aminoglycosid-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zusammensetzungen und solche derivate zur verwendung als arzneimittel.